Artificial Intelligence In Drug Discovery

Facts and opinions about machine learning for biomedical research
Phenomic AI Tackles Drug Discovery with AI-driven High-throughput Phenotypic Screens Using Antibody-based Assays
Naheed Kurji, CEO of Cyclica, on Building an AI Platform to Design, Screen, and Personalize Drugs
Nick Lynch of the Pistoia Alliance on AI as a Strategic Focus
Lucas Siow of ProteinQure on AI for Protein-Based Drugs
Regina Barzilay on AI for Small Molecule Discovery and Synthesis
Tim Guilliams and David Brown, Healx, on AI for Rare Diseases
John Cassidy, CEO of Cambridge Cancer Genomics, on AI-Powered Disease Prediction for Oncology
Kristen Fortney, CEO of BioAge Labs, on AI for Aging Research
Sam Cooper, CEO of Phenomic AI, on Automated HCS and More
Shai Shen-Orr, Chief Scientist of CytoReason, on AI for Systems Immunology
Leila Pirhaji, CEO of ReviveMed, on AI for Metabolomics
Mostapha Benhenda of Startcrowd on AI Drug Discovery Hype

Never miss a blog post